Triple
T18858075
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | major histocompatibility complex |
E461225
|
entity |
| Predicate | recognizedBy |
P653
|
FINISHED |
| Object | CD8+ T cells |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CD8+ T cells | Statement: [major histocompatibility complex, recognizedBy, CD8+ T cells]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: CD8+ T cells Context triple: [major histocompatibility complex, recognizedBy, CD8+ T cells]
-
A.
CD4+ T cells
CD4+ T cells are a subset of immune cells that coordinate and regulate the body’s adaptive immune response, playing a central role in defending against infections.
-
B.
B lymphocytes
B lymphocytes are a type of white blood cell central to the adaptive immune system, responsible for producing antibodies and mediating humoral immunity.
-
C.
CD3 complex
The CD3 complex is a multi-subunit protein complex associated with the T-cell receptor that is essential for T-cell activation and signal transduction in the immune system.
-
D.
CD19
CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
-
E.
Betz cells
Betz cells are large, pyramidal neurons in the primary motor cortex that play a key role in voluntary motor control by sending long axons to the spinal cord.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: CD8+ T cells Target entity description: CD8+ T cells are cytotoxic lymphocytes of the adaptive immune system that identify and kill infected or malignant cells by recognizing antigenic peptides presented on MHC class I molecules.
-
A.
CD4+ T cells
CD4+ T cells are a subset of immune cells that coordinate and regulate the body’s adaptive immune response, playing a central role in defending against infections.
-
B.
B lymphocytes
B lymphocytes are a type of white blood cell central to the adaptive immune system, responsible for producing antibodies and mediating humoral immunity.
-
C.
CD3 complex
The CD3 complex is a multi-subunit protein complex associated with the T-cell receptor that is essential for T-cell activation and signal transduction in the immune system.
-
D.
CD19
CD19 is a B-cell surface protein widely used as a key immunotherapy target in treatments for B-cell malignancies such as certain leukemias and lymphomas.
-
E.
Betz cells
Betz cells are large, pyramidal neurons in the primary motor cortex that play a key role in voluntary motor control by sending long axons to the spinal cord.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d8dcfb7b9c8190854e7b171b98ea2e |
completed | April 10, 2026, 11:20 a.m. |
| NER | Named-entity recognition | batch_69e5c05eaee881909da704cf1374158c |
completed | April 20, 2026, 5:57 a.m. |
Created at: April 10, 2026, 11:57 a.m.